tiprankstipranks
Doximity (DOCS)
NYSE:DOCS
US Market

Doximity (DOCS) Technical Analysis

Compare
727 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Doximity’s (DOCS) Moving Averages Convergence Divergence (MACD) indicator is -1.28, suggesting Doximity is a Buy.
Doximity’s (DOCS) 20-Day exponential moving average is 64.73, while Doximity’s (DOCS) share price is $62.99, making it a Sell.
Doximity’s (DOCS) 50-Day exponential moving average is 63.45, while Doximity’s (DOCS) share price is $62.99, making it a Sell.

Doximity (DOCS) Pivot Points

Mar 24, 2025, 11:00 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
58.56
60.28
61.52
63.24
64.48
66.20
67.44
Fibonacci
60.28
61.41
62.11
63.24
64.37
65.07
66.20
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Doximity (DOCS) Moving Averages

Mar 24, 2025, 11:00 PM
Period
Simple
Exponential
MA5
62.44Buy
62.70Buy
MA10
62.28Buy
63.31Sell
MA20
65.78Sell
64.73Sell
MA50
63.96Sell
63.45Sell
MA100
57.76Buy
58.06Buy
MA200
45.99Buy
47.43Buy
Doximity’s (DOCS) 10-Day exponential moving average is 63.31, while Doximity’s (DOCS) share price is $62.99, making it a Sell.
Doximity’s (DOCS) 100-Day exponential moving average is 58.06, while Doximity’s (DOCS) share price is $62.99, making it a Buy.
Doximity’s (DOCS) stock price is $62.99 and Doximity’s (DOCS) 50-day simple moving average is 63.96, creating a Sell signal.
Doximity’s (DOCS) stock price is $62.99 and Doximity’s (DOCS) 100-day simple moving average is 57.76, creating a Buy signal.
Doximity’s (DOCS) stock price is $62.99 and Doximity’s (DOCS) 200-day simple moving average is 45.99, creating a Buy signal.

Doximity (DOCS) Technical Indicators

Mar 24, 2025, 11:00 PM
Name
Value
Implied Action
RSI (14)
45.65
Neutral
STOCH (9,6)
53.08
Neutral
STOCHRSI (14)
27.48
Neutral
MACD (12,26)
-1.28
Buy
ADX (14)
16.45
Buy
Williams %R
-67.90
Buy
CCI (14)
-69.62
Neutral
ATR (14)
3.27
-
Ultimate Oscillator
44.23
Neutral
ROC
-7.98
Sell
Doximity’s (DOCS) Relative Strength Index (RSI) is 45.65, creating a Neutral signal.
Doximity’s (DOCS) Trend Strength Indicator (ADX) is 16.45, creating a Buy signal.
Doximity’s (DOCS) Commodity Channel Index (CCI) is -69.62, creating a Neutral signal.
Doximity’s (DOCS) Price Rate of Change (ROC) is -7.98, creating a Sell signal.

FAQ

Is DOCS a Buy, Hold, or Sell?
Based on DOCS’s technical indicators, DOCS is a Buy.
    What is DOCS’s RSI (14)?
    DOCS’s RSI (14) is 45.65, which suggests DOCS is a Neutral.
      What is DOCS’s MACD?
      DOCS’s MACD is -1.28, which suggests DOCS is a Buy.
        What is DOCS’s 5-day moving average?
        DOCS’s 5-day moving average is 62.44, which suggests DOCS is a Buy.
          What is DOCS’s 20-day moving average?
          DOCS 20-day moving average is 65.78, which suggests DOCS is a Sell.
            What is DOCS’s 50-day moving average?
            DOCS’s 50-day moving average is 63.96, which suggests DOCS is a Sell.
              What is DOCS’s 200-day moving average?
              DOCS’s 200-day moving average is 45.99, which suggests DOCS is a Buy.
                What is DOCS’s Williams % R (14)?
                DOCS’s Williams % R (14) is -67.90, which suggests DOCS is a Buy.
                  What is DOCS’s CCI (14)?
                  DOCS’s CCI (14) is -69.62, which suggests DOCS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis